Learning Resources

AAP Open Online

2021

Considerations for asthma management and viral transmission in the era of COVID-19
pp. 93-96(4)
Authors: Pitlick, Mitchell M.; Joshi, Avni Y.

Real-world mapping of allergy immunotherapy in the United States: The argument for improving adherence
pp. 55-64(10)
Authors: Stone, Brian; Rance, Karen; Waddell, Douglas; Aagren, Mark; Hammerby, Eva; Tkacz, Joseph P.

2020

The role of the allergist/immunologist in the COVID-19 pandemic: A Janus-faced presentation
pp. 397-412(16)
Author: Bellanti, Joseph A.

The allergist/immunologist, the Janus gatekeeper of inflammation, COVID-19 and beyond
pp. 395-396(2)
Authors: Bellanti, Joseph A.; Settipane, Russell A.

Eosinopenia could be a relevant prognostic biomarker in patients with coronavirus disease 2019
pp. e80-e82(3)
Authors: Perlini, Stefano; Ciprandi, Giorgio; Castagnoli, Riccardo; Licari, Amelia; Marseglia, Gian Luigi

Treg‐inducing capacity of genomic DNA of Bifidobacterium longum subsp. infantis
pp. 372-385(14)
Authors: Li, Dongmei; Cheng, Jie; Zhu, Ziang; Catalfamo, Marta; Goerlitz, David; Lawless, Oliver J.; Tallon, Luke; Sadzewicz, Lisa; Calderone, Richard; Bellanti, Joseph A.

Impact of mepolizumab on exacerbations in severe asthma: Results from a U.S. insurance claims data base
pp. 341-347(7)
Authors: Ortega, Hector; Hahn, Beth; Bogart, Michael; Bell, Christopher F.; Bancroft, Tim; Chastek, Benjamin; Llanos, Jean-Pierre

An evaluation of factors influencing response to epicutaneous immunotherapy for peanut allergy in the PEPITES trial
pp. 326-335(10)
Authors: Fleischer, David M.; Chinthrajah, Sharon; Scurlock, Amy M.; Campbell, Dianne E.; Green, Todd D.; Bee, Katharine J.; Peillon, Aurélie; Ocheltree, Terrance; Sampson, Hugh A.

Successful treatment of coronavirus disease 2019 in a patient with asthma
pp. 296-300(5)
Authors: Joshi, Avni Y.; Mullakary, Roshini M.; Iyer, Vivek N.

Evaluation of daily patch application duration for epicutaneous immunotherapy for peanut allergy
pp. 278-284(7)
Authors: Fleischer, David M.; Spergel, Jonathan M.; Kim, Edwin H.; Campbell, Dianne E.; Green, Todd D.; Bee, Katharine J.; Lambert, Romain; Ocheltree, Terrance; Sampson, Hugh A.

Deposition characteristics of a novel intranasal formulation of azelastine hydrochloride plus fluticasone propionate in an anatomic model of the human nasal cavity
pp. 265-270(6)
Authors: Meltzer, Eli O.; Bachert, Claus; Mayer, Michael J.; Kopietz, Ferdinand; Koltun, Arkady; Maus, Joachim; D’Addio, Alexander D.

Add-on tiotropium versus step-up inhaled corticosteroid plus long-acting beta-2‐agonist in real-world patients with asthma
pp. 248-255(8)
Authors: Chipps, Bradley; Mosnaim, Giselle; Mathur, Sameer K.; Shaikh, Asif; Khoury, Samir; Gopalan, Gokul; Palli, Swetha R.; Lamerato, Lois; Casciano, Julian; Dotiwala, Zenobia; Settipane, Russell

COVID-19, allergic disease and asthma: Extraordinary challenges for the allergist/immunologist
pp. 229-231(3)
Authors: Bellanti, Joseph A.; Settipane, Russell A.

Real-world cohort study of adult and pediatric patients treated for hereditary angioedema in the United States
pp. 172-182(11)
Authors: Tachdjian, Raffi; Johnson, Karin E.; Casso, Deborah; Oliveria, Susan A.; Devercelli, Giovanna; Jain, Gagan

Manufacturing of plasma-derived C1-inhibitor concentrate for treatment of patients with hereditary angioedema
pp. 99-107(9)
Authors: Simon, Toby L.; Kalina, Uwe; Laske, Reiner; Mycroft, Sarah; Widmer, Eleonora; Roth, Nathan J.

Long-term safety outcomes of prekallikrein (Fletcher factor) deficiency: A systematic literature review of case reports
pp. 10-18(9)
Authors: Girolami, Antonio; Rolland, Catherine; Sexton, Dan; Vardi, Moshe; Bernstein, Jonathan A.

Definition and classification of hereditary angioedema
pp. S03-S07(5)
Authors: Proper, Steven P.; Lavery, William J.; Bernstein, Jonathan A.

2019

Eosinopenia could be a relevant prognostic biomarker in patients with coronavirus disease 2019
pp. e80-e82(3)
Authors: Perlini, Stefano; Ciprandi, Giorgio; Castagnoli, Riccardo; Licari, Amelia; Marseglia, Gian Luigi

Long-term omalizumab outcomes in chronic idiopathic urticaria: a real-world study
pp. 321-328(8)
Authors: Kavati, Abhishek; Zhdanava, Maryia; Ortiz, Benjamin; LeCocq, Jason; Schiffman, Bradd; Pilon, Dominic; Ching Cheung, Hoi; Lefebvre, Patrick; Stone, Brian D.

Long-term safety and efficacy of olopatadine-mometasone combination nasal spray in patients with perennial allergic rhinitis
pp. 301-310(10)
Authors: Segall, Nathan; Prenner, Bruce; Lumry, William; Caracta, Cynthia F.; Tantry, Sudeesh K.

Olopatadine-mometasone combination nasal spray: Evaluation of efficacy and safety in patients with seasonal allergic rhinitis
pp. 261-272(12)
Authors: Hampel, Frank C.; Pedinoff, Andrew J.; Jacobs, Robert L.; Caracta, Cynthia F.; Tantry, Sudeesh K.

Current management and use of oral immunotherapy in the United States for patients with peanut allergy
pp. 214-220(7)
Authors: Blaiss, Michael S.; Tilles, Stephen; Petroni, Daniel; Zigmont, Ellen; Cassese, Marie; Kwak, Brian; Georgitseas, Nicholas; Liebermann, Jay

Disease burden in patients with asthma before initiating biologics: A retrospective cohort database study 
pp. 146-153(8)
Authors: Ortega, Hector; Hahn, Beth; Tran, Josephine N.; Bell, Chris; Shams, Salman A.; Llanos, Jean-Pierre

A cross-sectional, population-based survey of U.S. adults with symptoms of chronic rhinosinusitis 
pp. 48-56(9)
Authors: Palmer, James N.; Messina, John C.; Biletch, Robert; Grosel, Kirk; Mahmoud, Ramy A

2018

Human factors engineering validation study for a novel 0.1-mg epinephrine auto-injector 
pp. 461-465(5)
Authors: Edwards, Evan; Kessler, Catherine; Cherne, Naomi; Dissinger, Emily; Shames, Adam

Impact of patient satisfaction with his or her inhaler on adherence and asthma control 
pp. 437-444(8)
Authors: Plaza, Vicente; Giner, Jordi; Calle, Myriam; Rytilä, Paula; Campo, Carlos; Ribó, Paula; Valero, Antonio

Subcutaneous C1-esterase inhibitor to prevent hereditary angioedema attacks: Safety findings from the COMPACT trial 
pp. 365-370(6)
Authors: Li, H. Henry; Mycroft, Sarah; Christiansen, Sandra; Wood, Daniel N.; Feuersenger, Henrike; Pawaskar, Dipti; Jacobs, Iris

Efficacy of recombinant human C1 esterase inhibitor across anatomic locations in acute hereditary angioedema attacks 
pp. 359-364(6)
Authors: Baker, James W.; Bernstein, Jonathan A.; Harper, Joseph R.; Relan, Anurag; Riedl, Marc A.

Randomized dose-ranging study of a budesonide metered-dose inhaler by using co-suspension delivery technology in asthma 
pp. 350-358(9)
Authors: Miller, S. David; Nyberg, Jack; Siddiqui, Shahid; Dorinsky, Paul; St Rose, Earl; Reisner, Colin

Seasonal variability of exacerbations of severe, uncontrolled eosinophilic asthma and clinical benefits of benralizumab 
pp. 345-349(5)
Authors: DuBuske, Lawrence; Newbold, Paul; Wu, Yanping; Trudo, Frank

Cost impact of monitoring exhaled nitric oxide in asthma management 
pp. 338-344(7)
Authors: Arnold, Renée J.G.; Layton, Andrew; Massanari, Marc

Pharmacokinetics of intranasal mometasone in the fixed-dose combination GSP301 versus two monotherapy intranasal mometasone formulations 
pp. 232-239(8)
Authors: Patel, Piyush; Salapatek, Anne Marie; Talluri, Ravi S.; Tantry, Sudeesh K.

Pharmacokinetics of intranasal olopatadine in the fixed-dose combination GSP301 versus two monotherapy intranasal olopatadine formulations 
pp. 224-231(8)
Authors: Patel, Piyush; Salapatek, Anne Marie; Talluri, Ravi S.; Tantry, Sudeesh K.

Real-world use of omalizumab in patients with chronic idiopathic/spontaneous urticaria in the United States 
pp. 191-200(10)
Authors: Eghrari-Sabet, Jacqueline; Sher, Ellen; Kavati, Abhishek; Pilon, Dominic; Zhdanava, Maryia; Balp, Maria-Magdalena; Lefebvre, Patrick; Ortiz, Benjamin; Bernstein, Jonathan A.

The age-related characteristics of adults with asthma who visited emergency departments in Korea from 2007 to 2012 
pp. 136-142(7)
Authors: Lee, Mi-Hee; Seo, Hye-Jin; Shin, Eun Ju; Won, Youn Kyoung; Jung, Yu Mi; Suh, Seung-Hee; Jeong, Jin-young; Lim, Young Shil; Kim, You Young; Chung, Eun Hee

Asthma control, lung function, symptoms, and corticosteroid sparing after omalizumab initiation in patients with allergic asthma 
pp. 127-135(9)
Authors: Pilon, Dominic; Kavati, Abhishek; Ortiz, Benjamin; Paknis, Brandee; Vegesna, Ashok; Schiffman, Bradd; Zhdanava, Maryia; Lefebvre, Patrick; Stone, Brian

Randomized trial to assess the efficacy and safety of beclomethasone dipropionate breath-actuated inhaler in patients with asthma 
pp. 117-126(10)
Authors: Ostrom, Nancy K.; Raphael, Gordon; Tillinghast, Jeffrey; Hickey, Lisa; Small, Calvin J.

2017

Recombinant human C1 esterase inhibitor for acute hereditary angioedema attacks with upper airway involvement 
pp. 462-466(5)
Authors: Riedl, Marc A.; Li, H. Henry; Cicardi, Marco; Harper, Joseph R.; Relan, Anurag

Efficacy of recombinant human C1 esterase inhibitor for the treatment of severe hereditary angioedema attacks 
pp. 456-461(6)
Authors: Li, H. Henry; Reshef, Avner; Baker, James W.; Harper, Joseph R.; Relan, Anurag

Evaluation of beclomethasone dipropionate (80 and 160 micrograms/day) delivered via a breath-actuated inhaler for persistent asthma 
pp. 419-430(12)
Authors: Hampel, Frank C.; Carr, Warner; Gillespie, Michael; Small, Calvin J.

Fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers compared with placebo for persistent asthma 
pp. 343-353(11)
Authors: Sher, Lawrence D.; Yiu, Gloria; Sakov, Anat; Liu, Siyu; Caracta, Cynthia F.

A 6-month safety and efficacy study of fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers in persistent asthma 
pp. 264-276(13)
Authors: Mansfield, Lyndon; Yiu, Gloria; Sakov, Anat; Liu, Siyu; Caracta, Cynthia

Efficacy and safety of omalizumab in children and adolescents with moderate-to-severe asthma: A systematic literature review 
pp. 250-263(14)
Authors: Corren, Jonathan; Kavati, Abhishek; Ortiz, Benjamin; Colby, Jennifer A.; Ruiz, Kimberly; Maiese, Brett A.; Cadarette, Sarah M.; Panettieri, Reynold A.

Safety of a C1-inhibitor concentrate in pregnant women with hereditary angioedema 
pp. 216-221(6)
Authors: Fox, James; Vegh, Arthur B.; Martinez-Saguer, Inmaculada; Wuillemin, Walter A.; Edelman, Jonathan; Williams-Herman, Debora; Rojavin, Mikhail; Rosenberg, Tanja

Randomized, placebo-controlled study of cetirizine and loratadine in children with seasonal allergic rhinitis 
pp. 222-230(9)
Authors: Nayak, Anjuli S.; Berger, William E.; LaForce, Craig F.; Urdaneta, Eduardo R.; Patel, Mitesh K.; Franklin, Kathleen B.; Wu, Mei-Miau

State-of-the-art testing for alpha-1 antitrypsin deficiency 
pp. 108-114(7)
Authors: Kueppers, Friedrich; Sanders, Christopher

Albuterol multidose dry powder inhaler efficacy and safety versus placebo in children with asthma 
pp. 28-37(10)
Authors: LaForce, Craig; Taveras, Herminia; Iverson, Harald; Shore, Paul

2016

Corticosteroid-related toxicity in patients with chronic idiopathic urticaria‐chronic spontaneous urticaria 
pp. 458-465(8)
Authors: Ledford, Dennis; Broder, Michael S.; Antonova, Evgeniya; Omachi, Theodore A.; Chang, Eunice; Luskin, Allan

Pulmonologist perspectives regarding diagnosis and management of primary immunodeficiency diseases 
pp. e162-e168(7)
Authors: Orange, Jordan S.; Akhter, Javeed; Seeborg, Filiz O.; Boyle, Marcia; Scalchunes, Christopher; Hernandez-Trujillo, Vivian

MP-AzeFlu provides rapid and effective allergic rhinitis control in real life: A pan-European study 
pp. 376-386(11)
Authors: Klimek, Ludger; Bachert, Claus; Stjärne, Par; Dollner, Ralph; Larsen, Petter; Haahr, Peter; Agache, Ioana; Scadding, Glenis; Price, David

Albuterol multidose dry powder inhaler and albuterol hydrofluoroalkane versus placebo in children with persistent asthma 
pp. 350-358(9)
Authors: Qaqundah, Paul Y.; Taveras, Herminia; Iverson, Harald; Shore, Paul

2014 and older

Bronchodilator effect of single-dose formoterol administered by pressurized metered-dose inhaler in children with asthma aged 6 to <12 years receiving budesonide
pp. 134-140(7)
Authors: Berger, William E.; Gillen, Michael; Eckerwall, Göran; Uryniak, Tom; Trudo, Frank J.; Lampl, Kathy L.

Quality of life in patients with hereditary angioedema receiving therapy for routine prevention of attacks
pp. 371-376(6)
Authors: Lumry, William R.; Miller, Dave P.; Newcomer, Scott; Fitts, David; Dayno, Jeffrey

An algorithm for the management of allergic conjunctivitis 
pp. 408-420(13)
Authors: Bielory, Leonard; Meltzer, Eli O.; Nichols, Kelly K.; Melton, Ron; Thomas, Randall K.; Bartlett, Jimmy D.